Market Place
Sourcing Support
Saba Ilac Sanayive Generic Bimatoprost Receives Tentative Approval in US
13 Jun 2024 //
FDA
Sandoz must cough up $39M after losing Allergan patent fight
04 Apr 2023 //
FIERCE PHARMA
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit
03 Apr 2023 //
ENDPTS
Eugia`s Generic Bimatoprost Receives Approval in the U.S.
06 Oct 2022 //
FDA
Allergan to Present Data from its Leading Portfolio of Eye Care Treatments
24 Feb 2022 //
PRNEWSWIRE
Micro Labs`s Generic Bimatoprost Receives Approval In US
19 May 2021 //
FDA
FAMAR & Medicom announce the acquisition by Medicom dossier of BIMATOPROST
09 Feb 2021 //
PRESS RELEASE
Micro Labs`s Generic Bimatoprost Receives Approval In US
08 Sep 2020 //
FDA
Allergan Receives FDA Approval for DURYSTA
05 Mar 2020 //
PR NEWSWIRE
FDA approves Allergan`s long-term eye implant for glaucoma
05 Mar 2020 //
FIERCE BIOTECH
Allergan to Present New Data for Investigational Bimatoprost Sustained-Release
25 Feb 2020 //
PR NEWSWIRE
Alembic Pharma`s Generic Bimatoprost Receives Approval in U.S
21 Jan 2020 //
FDA
Enforcement Report - Week of January 8, 2020
08 Jan 2020 //
FDA
Enforcement Report - Week of November 6, 2019
06 Nov 2019 //
FDA
Alembic Pharma’s Generic Bimatoprost Receives Approval In US
09 Aug 2019 //
FDA
Somerset Therapeutics` Generic Bimatoprost Receives Approval in US
19 Jun 2019 //
FDA
Alembic Pharms Generic Bimatoprost Receives Approval in US
17 Apr 2019 //
FDA
Enforcement Report - Week of February 13, 2019
13 Feb 2019 //
FDA
Hi-Tech Pharma`s Generic Bimatoprost Receives Approval in US
13 Nov 2018 //
FDA
Gland Pharma`s Generic Bimatoprost Receives Tentative Approval in US
03 Nov 2018 //
FDA
Hi-Tech Pharmacal`s Generic Bimatoprost Receives Approval in US
10 Oct 2018 //
FDA
Latisse (bimatoprost) : Allergan, Duke University vs. Akorn
22 Sep 2018 //
PATENT LITIGATION
Alembic Pharms` Generic Bimatoprost Receives Tentative Approval in US
06 Aug 2018 //
FDA
Latisse® (bimatoprost): Duke University v. Alcon Laboratories
05 May 2018 //
PATENT LITIGATION
Latisse® (Bimatoprost Ophthalmic Sol): Duke University v. Sandoz
26 Apr 2018 //
PATENT LITIGATION
Latisse®(bimatoprost): Duke University et al v. Alcon Laboratories, Inc.
03 Apr 2018 //
PATENT LITIGATION
Latisse®(bimatoprost): Duke University et al v. Sandoz Inc
03 Apr 2018 //
PATENT LITIGATION
Latisse® Lumigan® (Bimatoprost): Sandoz &Alcon Lab V. Duke University, Allergan
14 Sep 2017 //
PATENT LITIGATION
Latisse® (Bimatoprost ): Duke University & Allergan Sales v. Sandoz & Alcon Laboratories
07 Jul 2017 //
PATENT LITIGATION
Enforcement Report - Week of April 19, 2017
19 Apr 2017 //
FDA
Allergan takes on preventable blindness with nationwide vision-screening push
09 Feb 2017 //
FIERCE PHARMA
Allergan Unveils Single-Digit Price Hikes for 9 Brand Name Drugs
04 Jan 2017 //
BIOSPACE
Fitch Affirms Allergan at `BBB-`; Outlook Stable
08 Dec 2016 //
REUTERS
Sienna Biopharmaceuticals Acquires Creabilis plc
06 Dec 2016 //
PR NEWSWIRE
Allergan breaks ground on $200 million waco facility expansion
26 Apr 2016 //
PR NEWSWIRE
Bay Area’s Relypsa) Stock Pops (Again) on More Buyout Rumors
22 Apr 2016 //
BIOSPACE
Independent study from Baylor University shows the economic impact of Allergan
29 Jan 2016 //
PR NEWS WIRE
Alcon`s Bimatoprost (0.03 %) Approved in USA For Ocular Hypertension
08 May 2015 //
FDA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
New Wave of Drugs Poised to Shake Up Glaucoma Treatment
16 Feb 2015 //
REUTERS
